1427 companies · 1448 sector slots · 21 sectors · 23 below Rs1000cr and not scanned · long-term lens
Trend Spotlight
Fed raises rates 25bp to 3.75%-4.00%, first hike since 2023, in a hawkish surprise for global risk assets.
New Fed Chair Kevin Warsh's FOMC unanimously hiked rates, saying inflation 'is too high and has been for too long,' and the updated dot plot shows 16 of 18 participants expecting another hike, four of them two more. US equities sold off into the announcement (Dow -1.2%, S&P 500 -0.4%) and the 10-year Treasury yield pushed above 5%, with futures pricing roughly 51% odds of a further October hike. For a long-term Indian holder this is a tighter global liquidity backdrop and a stronger dollar pressuring risk assets broadly, not a domestic catalyst.
GIFT Nifty points to a gap-down open as the Fed's hawkish hike combines with a weak rupee and sticky Indian inflation.
GIFT Nifty near 23,159 implies a lower Nifty 50 open, tracking the overnight US selloff. USD/INR is near 96/$ on a crude spike (Brent above $107-108/bbl) and dollar strength, while India's August CPI accelerated to 4.82% — a 10th straight monthly rise — pushing consensus toward the RBI holding rates at its Oct 5-7 MPC meeting rather than cutting. A narrower August trade deficit ($26.9bn vs $32.2bn consensus) is a partial offset. Nothing sector-specific is scheduled today; the overnight moves are macro, not company news.
Fii/dii cash flows published after The Close went out, and
is included below. The evening report names what it is
still waiting for, so nothing appears without having been declared missing first.
Calls this session
A change to anything but AVOID publishes only after two consecutive
sessions say the same thing; AVOID publishes at once.
Source: NSE event calendar, filtered to the 1427 tracked names.
Market Overview
Index
Close
Points
Change
P/E
P/B
Nifty 50
23,217.60
▲ +99.00
▲ +0.43%
19.63
2.81
Nifty Next 50
70,368.60
▲ +87.45
▲ +0.12%
18.60
3.13
Nifty 500
22,532.00
▲ +54.55
▲ +0.24%
21.83
3.13
Nifty Bank
56,292.45
▲ +497.70
▲ +0.89%
13.32
1.69
NIFTY Midcap 100
60,874.20
▼ -4.05
▼ -0.01%
29.34
4.18
▲ 1197 advancing■ 33 unchanged▼ 1414 decliningof 2644 equities, vs the 2026-09-15 close
Cash market, ₹ crore
FII / FPI net
▼ -2,032.61
bought 12,959 · sold 14,992
DII net
▲ +3,908.23
bought 15,280 · sold 11,371
FII / FPI
DII
Source: NSE ind_close_all_20260916
(levels, index P/E and P/B) and the full-market bhavcopy (breadth).
Index P/E from NSE's official daily index file.
Since We Flagged
The desk's track record — the FIRST call made on each standing name,
against its call today. Entry price is the close on the day of that first call, read
from the cached bhavcopy for that date. "Unchanged" means the original call still
stands.
FMCG leads sectoral gains on festive-demand optimism FMCG
Nestle India, ITC and HUL each rose more than 3% intraday as Nifty FMCG became the day's top-performing sectoral index, on expectations of a strong festive season. NIQ data show rural FMCG volume growth of 7.7% for the September quarter versus 3.7% urban, with overall volumes up 5.4% — a real but sentiment-led catalyst rather than a confirmed earnings print.
Novartis India ends Dr Reddy's distribution pact, re-licenses retina drugs from parent Pharmaceuticals
Novartis India's board approved terminating a distribution/promotion agreement with Dr Reddy's Laboratories effective September 30, 2026, to re-acquire exclusivity on certain products, while separately signing an exclusive Rs 10cr promotion/distribution deal with parent Novartis Healthcare for two retina medicines. A single-company portfolio reshuffle with the parent, not a sector-wide pharma catalyst — it does not explain today's NOVARTIND or FREDUN moves.
Hindustan Zinc: no new promoter-financing instance, no ED FEMA penalty found this session Metals & Mining
Checks on two open ledger claims found no third instance of the Vedanta group using HZL's shares or balance sheet to finance an unrelated obligation — the latest confirmed event was a full release of encumbrance following a JPMorgan facility prepayment — and no penalty or escalation yet in the ED's FEMA probe into royalty/brand-fee payments to the parent, which HZL says has not affected operations. Both claims remain open and unresolved.
Natco Pharma draws repeat FDA observations across two plants within a year Pharmaceuticals
The US FDA issued a 4-observation Form 483 at Natco's Visakhapatnam finished-dosage plant in August 2026, following 7 observations at the Chennai API unit earlier in the year (Voluntary Action Indicated, no warning letter). Neither has escalated, but a repeat pattern across two plants inside a year is a real quality-control watch item for the BUY call, alongside management's own guidance for a weaker FY27 before an FY28 recovery.
Indiabulls to acquire 70% of Fintech Cloud for Rs 1,050cr via NCLT scheme Commercial Services
Indiabulls Ltd announced plans to acquire a 70% stake in Fintech Cloud Private Limited for Rs 1,050 crore through an NCLT scheme, alongside its 19th AGM scheduled for September 28. Company-specific, consistent with the already-flagged HOLD-to-BUY call flip, and not itself a sector-wide catalyst — a separate 18-month-high in IT-services hiring is real but too modest to independently move the sector.
Entry score is 40% cheap-vs-history + 25% quality trend + 20% news catalyst + 15% technicals, for the 5 sectors with a researched catalyst. The other 16 show —: no catalyst was researched for them, so their score renormalises over the remaining three inputs rather than assuming a neutral headline. ≥62 accumulate · 45–61 watch · <45 avoid.
Source: data/verdicts.json × NSE sector index closes.
Stocks to Watch
Split evenly across large/mid/small/micro cap so this list isn't one
tier's picks — new calls first, then the highest long-term composites within each.
Micro-cap names are boxed and flagged Highly Volatile — worth
watching, not a call to buy — since their price swings run about twice every other
tier's. Each card shows the figures that selected it — open the desk for the full
six-lens panel.